Abstract
Amyloidosis is characterized by a heterogeneous group of diseases due to deposition of a fibrillar, proteinaceous material, in different tissues. In this review pathogenetic mechanisms, clinical and therapeutic findings of the most important aspects of the disease, are described.
Publication types
-
Comparative Study
-
Editorial
-
English Abstract
MeSH terms
-
Administration, Topical
-
Adrenal Cortex Hormones / therapeutic use
-
Amyloid / analysis
-
Amyloidosis* / diagnosis
-
Amyloidosis* / therapy
-
Anti-Bacterial Agents / therapeutic use
-
Anti-Inflammatory Agents / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Azathioprine / therapeutic use
-
Colchicine / therapeutic use
-
Diagnosis, Differential
-
Dimethyl Sulfoxide / therapeutic use
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Interferon Type I / therapeutic use
-
Middle Aged
-
Plasmapheresis
-
Prognosis
-
Recombinant Proteins
-
Serum Amyloid A Protein / analysis
-
Serum Amyloid P-Component / analysis
Substances
-
Adrenal Cortex Hormones
-
Amyloid
-
Anti-Bacterial Agents
-
Anti-Inflammatory Agents
-
Antineoplastic Agents
-
Immunosuppressive Agents
-
Interferon Type I
-
Recombinant Proteins
-
Serum Amyloid A Protein
-
Serum Amyloid P-Component
-
Azathioprine
-
Colchicine
-
Dimethyl Sulfoxide